AQP4 and myeloid sarcoma: A recent study aimed to compare AQP4 expression changes in metabolic (cuprizone toxin-induced demyelination) and autoimmune myelin injury (cuprizone + EAE) mice models and then tested in post-mortem tissue from progressive MS patients [114].